Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bolni Nagalo

Concepts (213)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Donors
11
2021
31
3.930
Why?
Hepatitis B
8
2023
23
2.110
Why?
Oncolytic Virotherapy
3
2022
18
1.690
Why?
HIV Infections
11
2021
353
1.590
Why?
Hepatitis B Surface Antigens
4
2018
9
1.520
Why?
Syphilis
7
2019
27
1.320
Why?
Liver Neoplasms
6
2025
329
1.290
Why?
Carcinoma, Hepatocellular
5
2025
194
1.210
Why?
Hepatitis C
5
2021
79
1.140
Why?
Blood Transfusion
3
2021
125
1.130
Why?
Seroepidemiologic Studies
10
2021
51
0.910
Why?
Burkina Faso
16
2023
16
0.890
Why?
Vesicular Stomatitis
1
2022
1
0.830
Why?
Enzyme-Linked Immunosorbent Assay
4
2018
244
0.750
Why?
Biliary Tract Neoplasms
4
2022
9
0.740
Why?
HIV Antibodies
1
2018
10
0.650
Why?
Blood-Borne Pathogens
1
2018
7
0.640
Why?
HIV-1
4
2018
53
0.590
Why?
Gabon
4
2019
4
0.520
Why?
Mass Screening
1
2018
346
0.510
Why?
Hepatitis B virus
3
2025
26
0.450
Why?
Rural Population
1
2018
546
0.450
Why?
Young Adult
11
2021
4013
0.450
Why?
Humans
37
2025
49863
0.430
Why?
Skin Neoplasms
3
2024
489
0.430
Why?
HIV Seroprevalence
2
2014
4
0.420
Why?
Vesiculovirus
2
2022
6
0.420
Why?
Bile Duct Neoplasms
2
2022
28
0.400
Why?
Cholangiocarcinoma
2
2022
26
0.400
Why?
Adult
17
2025
13325
0.390
Why?
Adolescent
10
2021
6392
0.380
Why?
Antibodies, Viral
1
2011
94
0.380
Why?
Plasma
1
2011
41
0.370
Why?
Communicable Diseases
1
2011
52
0.370
Why?
Polymorphism, Single Nucleotide
2
2025
483
0.340
Why?
Melanoma
2
2024
282
0.320
Why?
Middle Aged
13
2025
12258
0.290
Why?
Female
18
2025
26520
0.290
Why?
Prevalence
6
2018
951
0.290
Why?
Male
15
2025
25439
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
993
0.280
Why?
Cell Line, Tumor
4
2024
1387
0.270
Why?
Antineoplastic Agents
3
2024
1173
0.260
Why?
Sensitivity and Specificity
2
2018
855
0.260
Why?
Hepacivirus
2
2018
105
0.250
Why?
Cell Proliferation
4
2024
999
0.240
Why?
Extracellular Matrix Proteins
1
2025
69
0.240
Why?
Molecular Docking Simulation
2
2023
72
0.240
Why?
Monophenol Monooxygenase
1
2023
5
0.230
Why?
Animals
7
2024
13133
0.230
Why?
Incidence
2
2021
982
0.230
Why?
Carcinoma, Pancreatic Ductal
1
2024
32
0.220
Why?
Anti-HIV Agents
2
2014
42
0.220
Why?
Drug Synergism
2
2021
150
0.220
Why?
Doxorubicin
1
2024
233
0.210
Why?
Psoriasis
1
2023
29
0.210
Why?
Vesicular stomatitis Indiana virus
1
2022
4
0.210
Why?
Dermatitis
1
2023
36
0.210
Why?
Antioxidants
2
2023
237
0.200
Why?
Mice
5
2024
5671
0.200
Why?
Students, Medical
1
2023
158
0.190
Why?
Treponema pallidum
2
2018
10
0.190
Why?
Pancreatic Neoplasms
1
2024
209
0.190
Why?
Flavonols
1
2020
2
0.190
Why?
Risk Factors
4
2020
3597
0.180
Why?
Viral Proteins
1
2022
161
0.180
Why?
Disease Models, Animal
2
2023
1448
0.180
Why?
Cymbopogon
1
2020
1
0.180
Why?
Oils, Volatile
1
2020
12
0.180
Why?
Immunotherapy
2
2021
237
0.180
Why?
Receptors, KIR
1
2019
13
0.170
Why?
Sequence Deletion
1
2020
68
0.170
Why?
Protein Kinase Inhibitors
1
2021
205
0.170
Why?
Genotype
4
2025
534
0.170
Why?
Plasma Membrane Calcium-Transporting ATPases
1
2019
2
0.170
Why?
Retrospective Studies
6
2022
6106
0.170
Why?
Glutathione Transferase
1
2020
173
0.170
Why?
Polymorphism, Genetic
1
2020
181
0.170
Why?
Gene Frequency
3
2025
96
0.160
Why?
Virology
1
2018
6
0.160
Why?
Genetic Predisposition to Disease
4
2025
507
0.160
Why?
Anti-Inflammatory Agents
1
2020
160
0.160
Why?
HIV
1
2018
25
0.160
Why?
Aged
6
2022
9434
0.150
Why?
Case-Control Studies
4
2025
1129
0.150
Why?
Molecular Structure
3
2024
292
0.150
Why?
Immunotherapy, Adoptive
1
2018
157
0.140
Why?
Blood Pressure
1
2019
517
0.140
Why?
Odds Ratio
1
2018
547
0.130
Why?
T-Lymphocytes
1
2018
330
0.130
Why?
Polymerase Chain Reaction
2
2014
453
0.130
Why?
Cross-Sectional Studies
2
2018
1568
0.130
Why?
Cisplatin
3
2022
275
0.130
Why?
HIV-2
1
2014
1
0.120
Why?
Hospitals, Military
1
2014
7
0.120
Why?
Time Factors
2
2018
2889
0.120
Why?
Drug Monitoring
1
2014
78
0.120
Why?
Syphilis Serodiagnosis
1
2014
4
0.120
Why?
Antibodies, Monoclonal
1
2018
459
0.120
Why?
RNA, Viral
2
2014
124
0.120
Why?
Peritonitis
1
2014
27
0.120
Why?
Community-Acquired Infections
1
2014
39
0.120
Why?
Immunocompromised Host
1
2014
118
0.110
Why?
Viremia
1
2014
22
0.110
Why?
Neoplasms
1
2023
1233
0.110
Why?
Alleles
2
2025
251
0.110
Why?
Meningitis, Bacterial
1
2013
6
0.110
Why?
Infectious Disease Transmission, Vertical
1
2012
15
0.110
Why?
Rubella
1
2012
4
0.110
Why?
Antiretroviral Therapy, Highly Active
1
2012
33
0.110
Why?
Toxoplasmosis
1
2012
15
0.100
Why?
Antibodies, Protozoan
1
2012
12
0.100
Why?
Bacteria
1
2014
218
0.100
Why?
Bile Ducts, Intrahepatic
2
2022
15
0.100
Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.100
Why?
Pilot Projects
2
2013
700
0.100
Why?
Drug Screening Assays, Antitumor
2
2024
131
0.100
Why?
Apoptosis
3
2024
1102
0.100
Why?
TOR Serine-Threonine Kinases
2
2023
76
0.100
Why?
Liver Cirrhosis
2
2025
224
0.100
Why?
Pregnancy Complications, Infectious
1
2012
74
0.100
Why?
Structure-Activity Relationship
2
2024
396
0.090
Why?
Deoxycytidine
2
2021
28
0.090
Why?
Hospitals, Teaching
1
2011
53
0.090
Why?
Autophagy
2
2023
167
0.090
Why?
Tumor Microenvironment
2
2024
221
0.090
Why?
Xenograft Model Antitumor Assays
2
2021
212
0.090
Why?
Cohort Studies
2
2025
1400
0.090
Why?
Programmed Cell Death 1 Receptor
2
2021
40
0.090
Why?
Tumor Cells, Cultured
2
2020
460
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
594
0.080
Why?
Prospective Studies
2
2012
2341
0.080
Why?
Anti-Bacterial Agents
1
2014
743
0.080
Why?
Hepatitis B, Chronic
1
2025
17
0.060
Why?
Ionic Liquids
1
2024
1
0.060
Why?
Ablation Techniques
1
2024
21
0.060
Why?
Hydrogels
1
2024
16
0.060
Why?
Delayed-Action Preparations
1
2024
55
0.060
Why?
rho-Associated Kinases
1
2024
20
0.060
Why?
Hedgehog Proteins
1
2024
33
0.060
Why?
Blood Banks
2
2014
18
0.060
Why?
Azoles
1
2023
28
0.060
Why?
Immunomodulation
1
2024
37
0.060
Why?
Rabbits
1
2024
374
0.060
Why?
HLA-DRB1 Chains
1
2023
4
0.060
Why?
Research
1
2023
107
0.050
Why?
HLA Antigens
1
2023
53
0.050
Why?
Interleukin-17
1
2023
37
0.050
Why?
Medical Oncology
1
2023
95
0.050
Why?
Computer Simulation
1
2023
281
0.050
Why?
Pyrazoles
1
2023
114
0.050
Why?
Sirolimus
1
2023
62
0.050
Why?
Platinum
1
2022
11
0.050
Why?
Clone Cells
1
2022
78
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2023
156
0.050
Why?
Cyclin-Dependent Kinase 6
1
2021
2
0.050
Why?
Phosphatidylinositol 3-Kinases
1
2023
139
0.050
Why?
Cyclin-Dependent Kinase 4
1
2021
11
0.050
Why?
Program Evaluation
1
2023
349
0.050
Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2021
11
0.050
Why?
Pregnancy
3
2014
2469
0.050
Why?
Enzyme Inhibitors
1
2023
378
0.050
Why?
Cyclin-Dependent Kinase 2
1
2020
16
0.050
Why?
Proto-Oncogene Proteins c-kit
1
2020
36
0.050
Why?
Cytidine Monophosphate
1
2020
1
0.040
Why?
Curriculum
1
2023
397
0.040
Why?
Flame Ionization
1
2020
3
0.040
Why?
Medicine, Traditional
1
2020
18
0.040
Why?
Mice, Inbred NOD
1
2020
94
0.040
Why?
Plant Leaves
1
2020
40
0.040
Why?
Gas Chromatography-Mass Spectrometry
1
2020
66
0.040
Why?
Mice, SCID
1
2020
173
0.040
Why?
Aldehydes
1
2020
82
0.040
Why?
Cytokines
1
2023
612
0.040
Why?
Genomics
1
2021
284
0.040
Why?
Lipids
1
2020
147
0.040
Why?
DNA, Viral
1
2019
133
0.040
Why?
Sesquiterpenes
1
2020
88
0.040
Why?
Cell Survival
1
2020
590
0.040
Why?
Genetic Association Studies
1
2019
115
0.040
Why?
Inflammation
1
2023
602
0.040
Why?
CTLA-4 Antigen
1
2018
23
0.040
Why?
Immunohistochemistry
1
2021
983
0.040
Why?
Alcohol Drinking
1
2020
226
0.040
Why?
Rats
1
2024
3293
0.040
Why?
Neoplasm Recurrence, Local
1
2021
627
0.040
Why?
Dose-Response Relationship, Drug
1
2020
1354
0.040
Why?
Signal Transduction
1
2024
1605
0.040
Why?
Body Mass Index
1
2020
654
0.030
Why?
Phenotype
1
2019
727
0.030
Why?
Smoking
1
2020
505
0.030
Why?
CD4 Lymphocyte Count
1
2014
32
0.030
Why?
Aged, 80 and over
1
2022
3132
0.030
Why?
Risk Assessment
1
2019
1253
0.030
Why?
Opportunistic Infections
1
2014
58
0.030
Why?
Reagent Kits, Diagnostic
1
2014
18
0.030
Why?
Genotyping Techniques
1
2014
20
0.030
Why?
Hepatitis C Antibodies
1
2014
20
0.030
Why?
Donor Selection
1
2014
12
0.030
Why?
Drug Resistance, Bacterial
1
2014
72
0.030
Why?
Drug Therapy, Combination
1
2014
380
0.030
Why?
Weight Gain
1
2014
232
0.030
Why?
Microbial Sensitivity Tests
1
2014
271
0.030
Why?
Pregnancy Complications, Parasitic
1
2012
4
0.030
Why?
Antibodies, Anti-Idiotypic
1
2012
19
0.030
Why?
Molecular Diagnostic Techniques
1
2013
33
0.030
Why?
Water
1
2012
74
0.030
Why?
Comorbidity
1
2014
607
0.020
Why?
Disease Progression
1
2014
822
0.020
Why?
Socioeconomic Factors
1
2012
583
0.020
Why?
Follow-Up Studies
1
2014
2174
0.020
Why?
Treatment Outcome
1
2014
5165
0.010
Why?
Child
1
2012
6838
0.010
Why?
Nagalo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description